Dr. Reder is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S. MARYLAND AVE.
Neurology M/C 2030
Chicago, IL 60637Phone+1 773-702-6222Fax+1 773-702-9076
Education & Training
- University of MinnesotaResidency, Neurology, 1978 - 1982
- University of Michigan Medical SchoolClass of 1978
Certifications & Licensure
- IL State Medical License 1982 - 2026
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2015
- Chicago Magazine: Top Doctors Castle Connolly, 2004, 2006, 2008, 2010, 2012, 2014
Clinical Trials
- A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS) Start of enrollment: 2007 Mar 01
- Effect of MD1003 in Progressive Multiple Sclerosis (SPI2) Start of enrollment: 2016 Dec 01
- Mechanism of Action of Ocrelizumab in Multiple Sclerosis Start of enrollment: 2017 Oct 12
Publications & Presentations
PubMed
- 213 citationsVitamin D and Multiple Sclerosis: A Comprehensive ReviewMartina B. Sintzel, Mark Rametta, Anthony T. Reder
Neurology and Therapy. 2018-06-01 - 274 citationsBrief International Cognitive Assessment for MS (BICAMS): international standards for validationRalph H.B. Benedict, Maria Pia Amato, Jan Boringa, Bruno Brochet, Frederick W. Foley
BMC Neurology. 2012-07-16 - 24 citationsVitamin D enhances responses to interferon-β in MSXuan Feng, Zhe Wang, Quentin Howlett-Prieto, Nathan Einhorn, Suad Causevic
Neurology(R) Neuroimmunology & Neuroinflammation. 2019-11-01
Press Mentions
- Darren P. Baker, PhD a Pioneer in the Development of Pegylated Interferon-Β for Clinical UseMarch 1st, 2023
- New Study Shows Extent That Interferon Affects Activity of Immune Genes in People with MSNovember 7th, 2019
- New Multiple Sclerosis Treatment Offers Breakthrough for PatientsApril 20th, 2017
- Join now to see all
Research History
- NMSS Sylvia Lawry and NIH FellowMentor, Jack Antel1982 - 1984
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: